Second, ADT downregulated the conventional AR target gene PSA while selectively upregulating CCNA and TOP2A in CR-TSGs, as in human PCa [35], suggesting that the TSG model is a suitable platform for pre-clinical testing of the ever-growing number of new therapeutic agents that aim to better prevent AR activation in CRPC. Here, KLK3 is linked to posterior cortical atrophy.